Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial

ABSTRACT: Patients with COPD using long-term oxygen therapy (LTOT) over 15 h per day have improved outcomes. As inhalation of dry cold gas is detrimental to mucociliary clearance, humidified nasal high flow (NHF) oxygen may reduce frequency of exacerbations, while improving lung function and quality...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Thorax
Asıl Yazarlar: Fraser, John F, Spooner, Amy J, Dunster, Kimble R, Anstey, Chris M, Corley, Amanda
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2016
Konular:
Research Letter
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4975837/
https://ncbi.nlm.nih.gov/pubmed/27015801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2015-207962
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller